Author:
Bouw M. René,Chung Steve S.,Gidal Barry,King Aliceson,Tomasovic Jerry,Wheless James W.,Van Ess Peter J.
Subject
Neurology (clinical),Neurology
Reference19 articles.
1. Safety and pharmacodynamics of USL261, a novel formulation of midazolam optimized for intranasal administration, in subjects with epilepsy;Altman;Epilepsy Curr.,2013
2. Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers;Bancke;Epilepsia,2015
3. Pharmacokinetics of midazolam nasal spray in pediatric subjects with epilepsy;Berg;American Epilepsy Society 70th Annual Meeting,2016
4. Pharmacokinetics, pharmacodynamics, and tolerability of USL261, midazolam nasal spray: randomized study in healthy geriatric and non-geriatric adults;Berg;Epilepsy Behav.,2017
5. Validity and reliability of the Observer’s Assessment of Alertness/Sedation Scale: study with intravenous midazolam;Chernik;J. Clin. Psychopharmacol.,1990
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献